Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,116 across all filing types
Latest filing 2021-08-10 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
公司章程（2021年8月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Sailong Pharmaceutical Group Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, share transfer, shareholder meetings, and other governance matters. It references relevant laws and regulations and includes detailed chapters on the company's governance framework. This type of document is a governance charter or internal rules document that governs the company's operations and shareholder relations. It is not a financial report, audit report, earnings release, or any announcement. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains the full text of the company's articles, not just an announcement or summary.
2021-08-10 Chinese
第三届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the third session of the fourth board meeting of Zhuhai Sailong Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, and the approval of several proposals including a company name change, amendments to the articles of association, and the calling of a second extraordinary general meeting of shareholders. The document includes voting results and references to related announcements published elsewhere. It does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and it is an announcement of decisions made by the board, not a full report or regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2021-08-10 Chinese
公司章程修正案
Governance Information Classification · 95% confidence The document is a corporate announcement regarding amendments to the company's Articles of Association (公司章程), specifically a name change and related updates. It is a formal board resolution requiring shareholder approval but does not contain financial data, audit information, or detailed report content. The document length is short (1127 characters) and it is not a full report but a governance-related announcement. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-08-10 Chinese
关于变更公司名称的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding a change in its company name. It includes details about the proposed new name, the legal and procedural background, and the need for shareholder approval. There is no financial data, no report attached or referenced as being published, and no mention of an annual or interim report. The document is a formal regulatory announcement about a corporate action (name change) rather than a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-10 Chinese
关于召开2021年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2021 second extraordinary general meeting of shareholders for Zhuhai Sailong Pharmaceutical Co., Ltd. It details the meeting date, voting procedures, agenda items including proposals to change the company name and amend the articles of association, and instructions for proxy voting. There are no financial statements or financial performance data included. The document is an announcement informing shareholders about the meeting and how to participate, rather than the actual meeting minutes or voting results. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2021-08-10 Chinese
独立董事关于第三届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters related to the company's third board meeting, specifically regarding a proposed company name change. It references compliance with laws and company articles but does not contain financial data or detailed management reports. The document is short (770 characters) and appears to be a formal opinion or statement related to board matters rather than a full report or announcement of voting results. It fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent director opinions.
2021-08-10 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.